APT Medical Inc. Overview
Pro stress-test →APT Medical engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company has formed a business layout dominated by complete coronary pathways and electrophysiological medical devices, with peripheral vascular and neurological interventional medical devices as the main development direction. The company operates in a high-growth medical devices sector targeting interventional cardiology and electrophysiology procedures.
Strategic Profile
Pro stress-test →In 2024, APT Medical's revenue was 2.07 billion, an increase of 25.18% compared to the previous year's 1.65 billion. APT Medical Inc. was founded in 2002 and is based in Shenzhen, China. The company is positioned as a leading supplier of specialized medical devices in the Asian market with strong R&D capabilities and OEM/ODM service offerings.
Competitive Landscape
Pro stress-test →APT Medical competes in China's growing interventional medtech market against both domestic and international players. The company's strength lies in specialized electrophysiology and interventional cardiology devices serving Chinese healthcare facilities and export markets. Competitive advantages include established distribution networks, regulatory approvals, and OEM/ODM capabilities.
Industry Context
APT Medical Inc. operates in Medical Devices & Equipment Manufacturing - Cardiovascular Interventional Devices.
Key facts
Founded: 2002 · Headquarters: Shenzhen, China · Revenue: $2.07B (2024) · Market cap: $4.82B